| For: | Huang XY, Zhong QH, Kuang YY, Li ZJ, Huang BJ, He YJ, Zhu MM, Guan Q, Li XY, Qin QY, Ma TH. Thalidomide for refractory hemorrhagic chronic radiation proctitis secondary to pelvic malignancy radiotherapy: A phase II clinical trial. World J Gastroenterol 2026; 32(14): 116529 [DOI: 10.3748/wjg.v32.i14.116529] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v32/i14/116529.htm |
| Number | Citing Articles |
| 1 |
Ya Deng, Zhi-Min Du, Hong-Fang Li, Fu-Shan Tang. Thalidomide for refractory hemorrhagic chronic radiation proctitis: Bridging the gap between symptom control and disease-modifying therapy. World Journal of Gastroenterology 2026; 32(38): 120289 doi: 10.3748/wjg.120289
|
| 2 |
Sai-Han Zhang, Yu-Bo Wang, Bing Chang. Letter to the Editor: From hemostasis to healing – rethinking the therapeutic paradigm for chronic radiation proctitis. World Journal of Gastrointestinal Surgery 2026; 18(10): 125545 doi: 10.4240/wjgs.125545
|